Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$9.3 million.

  • Sunshine Biopharma's Enterprise Value rose 2375.93% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.3 million, marking a year-over-year increase of 2375.93%. This contributed to the annual value of -$9.7 million for FY2024, which is 4054.55% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Enterprise Value of -$9.3 million as of Q3 2025, which was up 2375.93% from -$10.3 million recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Enterprise Value peaked at -$1.7 million during Q2 2021, and registered a low of -$41.7 million during Q2 2022.
  • Its 5-year average for Enterprise Value is -$14.6 million, with a median of -$12.2 million in 2024.
  • Per our database at Business Quant, Sunshine Biopharma's Enterprise Value tumbled by 970642.46% in 2021 and then skyrocketed by 5353.92% in 2023.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Enterprise Value stood at -$2.1 million in 2021, then tumbled by 963.27% to -$21.8 million in 2022, then increased by 25.35% to -$16.3 million in 2023, then soared by 40.55% to -$9.7 million in 2024, then increased by 3.92% to -$9.3 million in 2025.
  • Its Enterprise Value stands at -$9.3 million for Q3 2025, versus -$10.3 million for Q2 2025 and -$8.2 million for Q1 2025.